scholarly journals National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: The Need for Pediatric-Specific Long-Term Follow-up Guidelines

2012 ◽  
Vol 18 (3) ◽  
pp. 334-347 ◽  
Author(s):  
Michael A. Pulsipher ◽  
Roderick Skinner ◽  
George B. McDonald ◽  
Sangeeta Hingorani ◽  
Saro H. Armenian ◽  
...  
Keyword(s):  
National Cancer Institute ◽  
Hematopoietic Cell Transplantation ◽  
Consensus Conference ◽  
International Consensus ◽  
Blood Institute ◽  
Blood And Marrow Transplantation ◽  
National Heart Lung ◽  
Long Term Follow Up

Long-term follow-up of coronary angioplasty: the 1977-1981 national heart, lung, and blood institute registry

1989 ◽  
Vol 10 (suppl G) ◽  
pp. 36-41 ◽  
Author(s):  
M.G. Bourassa ◽  
J. W. Wilson ◽  
K. M. Detre ◽  
S. F. Kelsey ◽  
T. Robertson ◽  
...  
Keyword(s):  
Coronary Angioplasty ◽  
Blood Institute ◽  
National Heart ◽  
National Heart Lung ◽  
Long Term Follow Up

scholarly journals Remote long-term follow-up clinic after hematopoietic cell transplantation using internet telemedicine: a single-institute experience

2021 ◽  
Vol 10 (2) ◽  
pp. 113-117
Author(s):  
Toshiki Mushino ◽  
Akinori Nishikawa ◽  
Yoshikazu Hori ◽  
Hideki Kosako ◽  
Yuichi Tochino ◽  
...  
Keyword(s):  
Cell Transplantation ◽  
Hematopoietic Cell Transplantation ◽  
Hematopoietic Cell ◽  
Long Term Follow Up

Joint ultrasound baseline abnormalities predict a specific long-term clinical outcome in systemic lupus erythematosus patients

Lupus ◽  
2016 ◽  
Vol 26 (7) ◽  
pp. 729-733 ◽  
Author(s):  
P Corzo ◽  
T C Salman-Monte ◽  
V Torrente-Segarra ◽  
L Polino ◽  
S Mojal ◽  
...  
Keyword(s):  
Systemic Lupus Erythematosus ◽  
Lupus Erythematosus ◽  
Activity Index ◽  
Consensus Conference ◽  
Clinical Activity ◽  
Systemic Lupus ◽  
International Consensus ◽  
Musculoskeletal Involvement

Objective To describe long-term clinical and serological outcome in all systemic lupus erythematosus (SLE) domains in SLE patients with hand arthralgia (HA) and joint ultrasound (JUS) inflammatory abnormalities, and to compare them with asymptomatic SLE patients with normal JUS. Methods SLE patients with HA who presented JUS inflammatory abnormalities (‘cases’) and SLE patients without HA who did not exhibit JUS abnormalities at baseline (‘controls’) were included. All SLE clinical and serological domain involvement data were collected. End follow-up clinical activity and damage scores (systemic lupus erythematosus disease activity index (SLEDAI), Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR)) were recorded. JUS inflammatory abnormalities were defined based on the Proceedings of the Seventh International Consensus Conference on Outcome Measures in Rheumatology Clinical Trials (OMERACT-7) definitions. Statistical analyses were carried out to compare ‘cases’ and ‘controls’. Results A total of 35 patients were recruited. The ‘cases’, n = 18/35, had a higher incidence of musculoskeletal involvement (arthralgia and/or arthritis) through the follow-up period (38.9% vs 0%, p = 0.008) and received more hydroxychloroquine (61.1% vs 25.0%, p = 0.034) and methotrexate (27.8% vs 0%, p = 0.046) compared to ‘controls’, n = 17/35. Other comparisons did not reveal any statistical differences. Conclusions We found SLE patients with arthralgia who presented JUS inflammatory abnormalities received more hydroxychloroquine and methotrexate, mainly due to persistent musculoskeletal involvement over time. JUS appears to be a useful technique for predicting worse musculoskeletal outcome in SLE patients.

Sign in / Sign up

Export Citation Format

Share Document